Article
Advances in Single-Cell Sequencing Technology and Its Applications in Triple-Negative Breast Cancer
1 Dec 2022
Abstract excerpt
Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer and is mainly treated with chemotherapy-based combination therapy. In recent years, with the increasing development of global precision medicine, single-cell sequencing (SCS) has become one of the most promising technologies in the field of biotechnology. Moreover, the related application of this technology in TNBC has been...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
